OraVax, Peptide Therapeutics and Pasteur Merieux Connaught announce agreements Feb. 1, 1999 No Comments
Antex Biologics successfully completes phase I study of Helicobacter vaccine Jan. 29, 1999 No Comments
Yoshitomi's new immunosuppressive agents for arthritis, autoimmune diseases and transplant rejection Jan. 27, 1999 No Comments